Panelists MUST Read the Following Panelist Biosafety Procedure Before Coming to the Facility

Call us at 973-965-8195 x5 with any questions.

Panelist Biosafety Information

The health of our panelists and staff are our primary concern. Panelists will be contacted to schedule appointments for all studies, including patch tests. You will only be admitted into the facility if you have a scheduled appointment.

Consumer Product Testing℠ Company, Inc. (CPT℠) has implemented a Biosafety and Security Policy, with the core objective of establishing sustainable safe operations for our employees and panelists, as a result of the COVID-19 pandemic. We based our policy upon analyzing best practices and guidance from the Centers for Disease Control and Prevention (CDC), Occupational Safety and Health Administration (OSHA), National Safety Council (NSC) and local and state guidance in New Jersey.

Play Video
See All Current Studies
When you arrive at our facility, the new precautionary and safety procedures outlined below will help keep you and our staff safe during these challenging times.
  • Panelists will be contacted prior to their initiation in any special project or photobiology clinical trial to have their general health assessed. Any panelist noting or exhibiting signs of COVID‐19 will not be scheduled for such clinical trial, and will be turned away from our facility, should they appear.
  • Panelists will be required to arrive at the facility 15 minutes prior to their scheduled time for special studies or photobiology studies.  Personal items, other than identification required for participation, will be limited in the facility.
  • Panelists will be allowed to have minor children accompany them into the facility for their patch testing appointment.  All minor children who accompany their parent/legal guardian will be required to follow the same Biosafety procedures as the panelist on a panel.  The parent/legal guardian will be responsible to ensure that any children brought into the facility do not stray from the panelist, and do not touch the curtains, door handles etc.  The parent/legal guardian will be required to sign a waiver for any minor child that they bring into the facility.
  • Panelists and children over the age of 2, will be required to wear masks that meet minimum standards for their protection and the safety of our staff.  If the security officers deem that a mask does not meet the minimum standards you will not be allowed in the building.
  • Panelists and any accompanying child, who are scheduled for a trial, will have their temperature taken for a Pass/Fail (>100.4), and any person that fails will not be admitted to the facility.
  • Panelists and any accompanying child, who are admitted into the facility, will sanitize their hands prior to entering, and when leaving, the facility.
  • Panelists and any accompanying child, shall refrain from touching hard surfaces, such as doorknobs, counters, and benches.
  • Panelists shall be provided trial documents, that need to be read and signed, in a container which will be sanitized after each use. Their daily schedule, instructions, and additional study paperwork, will be provided in this sealed plastic zip‐lock bag.  Each time that panelists arrive for their clinical trial, they will return with their trial documents in that sealed plastic zip‐lock bag.
  • Panelists shall not loiter in the building, but will exit the building immediately upon completion of  their trial visit. 

We want to make all of our panelists feel comfortable when participating in studies at our facility. We will be doing our best to make this a positive experience for all of our panelists. Thank you for participating at CPT℠ and we hope to see you soon.

Effective July 14, 2022

CPT management, in conjunction with our corporate attorney, has generated a risk assessment, in reference to Executive Order 242, 243 and 292. Based upon the following factors, we are transitioning to Phase II of our BioSafety and Security Policy, effective July 14, 2022.

  • Activities were assessed for the criteria defined as ‘close-contact’.
  • CDC and OSHA risk assessment levels were assigned based upon the OSHA risk pyramid for Lower, Medium, High and Very High Risk.
  • A Risk Category was then applied to all staff positions, which were based upon vaccination status and activity performed.
  • Monitoring COVID infection rates in the County of Essex for the period of April, May and June 2022.

Please be advised that CPT has also created fallback rules and guidance, in case heightened safety precautions must be reinstated to our current BioSafety and Security Policy, or Transition Phase I.

The factors that will go into that decision would be based on:

CDC Guidelines

  • CDC guidance which indicates that masking be re-instated in public and non-public facilities, will trigger a re-instatement of masking, to an appropriate degree, in CPT facilities for vaccinated and unvaccinated employees.

OSHA Risk Assessment

  • OSHA guidance in which the risk pyramid parameters indicate that an increased risk is inherent in any position at CPT, requires revision to that position biosafety policy (eg. Masking, physical distancing etc.)

Covid-19 Activity Level Report [CALI] Activity Levels – NJ Dept of Health

  • CALI level increase to High or Very High, indicating an increase in transmission, case, and hospitalization rates, requires reverting to the original, or Transition Phase I BioSafety and Security Policy.
See All Current Studies

Call us at 973-965-8195 x5 with any questions!